Literature DB >> 16896579

Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.

D I Cohen1, B B Davidovici, Z Smetana, R D Balicer, E Klement, E Mendelson, M S Green.   

Abstract

OBJECTIVES: This large-scale study provides up-to-date estimates of Varicella zoster virus (VZV) age-specific seroprevalence and characteristics of VZV transmission in a representative sample of the Israeli population.
METHODS: In 2000-2001, 1,642 sera collected from an agestratified general population sample were tested for VZV antibodies using an indirect IgG ELISA system.
RESULTS: The age-weighted VZV overall estimate was 90.2%. Seropositivity increased rapidly with age, from 68.9% at age 4 to 94.4% at age 7 and 96.6% at age 12 years. The highest force of infection was in the 4-5 years age group (0.548 per susceptible year) followed by the 6-9 years age group. Multivariate analysis revealed that VZV seroprevalence estimates were significantly associated with age and place of origin. The highest seroprevalence estimate was found among subjects of Eastern origin.
CONCLUSIONS: The seroepidemiology of VZV in Israel shows a pattern corresponding to that described for developed European countries. This study indicates that the highest force of infection is in pre-school children. Knowledge of pre-vaccination seroepidemiology is important to evaluate the effect of vaccination programs on the epidemiology of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896579     DOI: 10.1007/s15010-006-6604-4

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  Secular trends of chickenpox among military population in Israel in relation to introduction of varicella zoster vaccine 1979-2010.

Authors:  Daniel Mimouni; Hagai Levine; Anat Tzurel Ferber; Inbal Rajuan-Galor; Michael Huerta-Hartal
Journal:  Hum Vaccin Immunother       Date:  2013-02-14       Impact factor: 3.452

2.  Comparison of the dynamics and correlates of transmission of Herpes Simplex Virus-1 (HSV-1) and Varicella-Zoster Virus (VZV) in a sample of the Israeli population.

Authors:  Batya B Davidovici; Ran D Balicer; Eyal Klement; Manfred S Green; Ella Mendelson; Zehava Smetana; Dani I Cohen
Journal:  Eur J Epidemiol       Date:  2007-08-01       Impact factor: 8.082

3.  Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.

Authors:  Gini G C van Rijckevorsel; Marjolein Damen; Gerard J Sonder; Maarten F Schim van der Loeff; Anneke van den Hoek
Journal:  BMC Infect Dis       Date:  2012-06-21       Impact factor: 3.090

4.  Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain).

Authors:  Lluís Salleras; Angela Domínguez; Pere Plans; Josep Costa; Neus Cardeñosa; Núria Torner; Antoni Plasència
Journal:  Med Microbiol Immunol       Date:  2007-11-15       Impact factor: 4.148

5.  Sero-Prevalence of Antibodies against Varicella Zoster Virus in Children under Seven-Years Old in 2012 in Tehran, Iran.

Authors:  Yasaman Vojgani; Saeed Zarei; Samira Rajaei; Leili Chamani-Tabriz; Fatemeh Ghaemimanesh; Nematallah Mohammadinia; Mahmood Jeddi-Tehrani
Journal:  Iran J Public Health       Date:  2014-11       Impact factor: 1.429

6.  Spatial and temporal distribution of West Nile virus in horses in Israel (1997-2013)--from endemic to epidemics.

Authors:  Karin Aharonson-Raz; Anat Lichter-Peled; Shlomit Tal; Boris Gelman; Daniel Cohen; Eyal Klement; Amir Steinman
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

7.  Varicella zoster virus transmission dynamics in Vojvodina, Serbia.

Authors:  Snežana Medić; Michalis Katsilieris; Zagorka Lozanov-Crvenković; Constantinos I Siettos; Vladimir Petrović; Vesna Milošević; Snežana Brkić; Nick Andrews; Milan Ubavić; Cleo Anastassopoulou
Journal:  PLoS One       Date:  2018-03-05       Impact factor: 3.240

8.  Global aspects of viral glycosylation.

Authors:  Ieva Bagdonaite; Hans H Wandall
Journal:  Glycobiology       Date:  2018-07-01       Impact factor: 4.313

9.  Seroprevalence of varicella-zoster virus among pregnant women in Fayoum Governorate, Egypt.

Authors:  Enas G Ibrahim; Wafaa Y Abdel Wahed; Hanaa M Eid; Wessam S Deeb
Journal:  J Egypt Public Health Assoc       Date:  2019-01-07

10.  Systematic analysis of infectious disease outcomes by age shows lowest severity in school-age children.

Authors:  Judith R Glynn; Paul A H Moss
Journal:  Sci Data       Date:  2020-10-15       Impact factor: 6.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.